Single answer
Is Applied DNA Sciences Inc (APDN) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Applied DNA Sciences Inc is $1.500, which is $4.12 (73.31%) below the current price today's price.
Low target: $1.500 | High target: $1.500
Company snapshot
A quick overview of the business and its public profile.
Applied DNA Sciences Inc develops and markets DNAbased technology solutions for use in the nucleic acidbased in vitro diagnostics and preclinical nucleicacid based drug development and manufacturing markets and for supply chain security anticounterfeiting and antitheft technology purposes The companys supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security as well as mark track and convict criminals SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide realtime authentication of molecular tags in the field and CertainT which indicates the use of tagging testing and tracking platforms and solutions enabling manufacturers brands and trade organizations to convey proof of their product claims It also manufactures and sells COVID19 PCRbased molecular diagnostic test kit under the LineaTM COVID19 Assay Kit trademark and COVID19 diagnostic test kit to prevent virus spread within a community school or workplace under the safeCircle trademark In addition the company provides preclinical contract research and manufacturing services for the nucleic acidbased therapeutic markets and contract research services to RNA based drug and biologic customers for preclinical studies Further it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes The company operates in the United States Europe Asia and internationally The company was formerly known as Datalink Systems Inc and changed its name to Applied DNA Sciences Inc in 2002 Applied DNA Sciences Inc was founded in 1983 and is headquartered in Stony Brook New York
Website: https://www.adnas.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: -295.98. Net profit margin: -5,676.69%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Applied DNA Sciences Inc is $4.2M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Applied DNA Sciences Inc, 2016-02-26 had a stock price of $2,232.00. If you invested back then, your return now would be a loss of $2,228.60 per share or 99.85%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.